{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whooping-cough/diagnosis/notification-confirmation/","result":{"pageContext":{"chapter":{"id":"95029ae8-217f-53b1-b552-1b19a63a1460","slug":"notification-confirmation","fullItemName":"Notification and confirmation","depth":2,"htmlHeader":"<!-- begin field 8e91a1b7-c17a-4ad4-94b0-06dd55c19aa5 --><h2>Notification and confirmation</h2><!-- end field 8e91a1b7-c17a-4ad4-94b0-06dd55c19aa5 -->","summary":"","htmlStringContent":"<!-- begin item 533aaa24-eb9c-483f-a205-30a59e27503d --><!-- begin field 9875d08e-c293-42dc-bcfc-4099ffc3d19d --><ul><li><strong>Whooping cough is a notifiable disease. </strong>If there is any suspicion of infection because of clinical features, a <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/324450/Notifiable_disease_form.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"62792941-d25a-4771-af5e-a93100a8eafd\">notification form</a> should be completed and sent to the local Public Health England (PHE) centre within 3 days.</li><li><strong>The local health protection team can advise on appropriate tests for confirmation and surveillance. </strong>This will depend on the person's age, the duration of symptoms, and on local laboratory facilities.<ul><li>If the cough is of 2 weeks’ duration or less, culture of a nasopharyngeal aspirate or nasopharyngeal/pernasal swabs is recommended for people of all ages. However, a negative result does not exclude pertussis.</li><li>Real-time PCR testing of nasopharyngeal or throat swabs can also be used to confirm infection in people of all ages with symptoms of less than three weeks' duration.</li><li>If the cough is of more than 2 weeks’ duration, anti-pertussis toxin immunoglobulin G (IgG) serology may be employed in people aged over 17 years. Anti-pertussis toxin IgG detection in oral fluid can be used in children aged 5 to 16 years.</li><li>Be aware that serology and oral fluid test results may be confounded by receipt of a primary or booster dose of pertussis-containing vaccine within the last year. It is also more difficult to recover the organism in vaccinated compared with unvaccinated children, which may affect culture results.</li></ul></li><li><strong>Whooping cough is confirmed when a person with clinical features of pertussis has:</strong><ul><li><em>Bordetella pertussis </em>isolated from a nasopharyngeal aspirate or nasopharyngeal/pernasal swab, <em>or</em></li><li>Detection by real-time PCR of the pertussis toxin S1 promoter region (ptxA-pr), and the insertion element IS481, <em>or</em></li><li>Anti-pertussis toxin IgG detected in serum or oral fluid in the absence of vaccination within the past year.</li></ul></li></ul><!-- end field 9875d08e-c293-42dc-bcfc-4099ffc3d19d --><!-- end item 533aaa24-eb9c-483f-a205-30a59e27503d -->","topic":{"id":"35659c4f-d80b-5e8b-8b62-22146482d6da","topicId":"aa36f776-3bec-44aa-ba6f-c147b57f7328","topicName":"Whooping cough","slug":"whooping-cough","lastRevised":"Last revised in January 2021","chapters":[{"id":"57f71ac2-7f00-5c54-b9dc-d2d7d9425e4f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"43ee7c18-a7d1-5aaf-b7b1-e9f8aec21522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c127e190-a190-5b44-9ef6-9f30b6527b35","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"86a8dc5e-4401-57e4-a893-30e9405e7e8d","slug":"changes","fullItemName":"Changes"},{"id":"f0e375ca-3710-5454-996c-600b6987bc09","slug":"update","fullItemName":"Update"}]},{"id":"9165fc1a-9d30-5e58-9bb2-a1b68eab43c6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"39a4fa70-e2db-566b-9c9e-0be39b8be0ac","slug":"goals","fullItemName":"Goals"},{"id":"7fd8bab1-ed01-583f-925f-50b956b1065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4c330a84-fe34-5261-acf3-bcd6c9b9d2ef","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"dab08320-4d0b-59e9-b25a-28f9cc15908b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a088fcbf-b960-56c1-a102-2cb980dc3cb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05a22688-4243-5ec9-814d-874c82306da6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"32d067f6-839d-500a-9f89-494e3487c3fd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"76a32750-044c-5bf9-b055-60be74d61d05","slug":"definition","fullItemName":"Definition"},{"id":"ba541f69-d5c7-5bfb-bcef-ec03ceaceee7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5d07a89e-bdd9-5e79-81eb-87c32d271af2","slug":"prognosis","fullItemName":"Prognosis"},{"id":"054c3198-af7f-5c25-8611-2cc61ad8a848","slug":"complications","fullItemName":"Complications"}]},{"id":"41fa1350-a42e-56da-b04d-aba216545b35","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6eb9d7f5-32ca-5aaa-b5f3-1ac34aeff0d6","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"02ae0369-3f8d-5a31-b677-d0a1d5d0e6f9","slug":"making-a-clinical-diagnosis","fullItemName":"Making a clinical diagnosis"},{"id":"0a55b0ed-e1e6-5bf2-a57c-ec4bda345338","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"95029ae8-217f-53b1-b552-1b19a63a1460","slug":"notification-confirmation","fullItemName":"Notification and confirmation"}]},{"id":"e9f5a777-75d4-5e44-9222-d0679a35b79f","fullItemName":"Management","slug":"management","subChapters":[{"id":"be786901-8aa4-5cf6-977f-07c667507f85","slug":"management-of-whooping-cough","fullItemName":"Scenario: Management of whooping cough"}]},{"id":"73184dce-2f33-555a-99f5-1f7676165d85","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"c6240279-15ed-57da-bbbc-a009ed1fe10d","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"f55a7bd1-232f-5264-b591-1615754d7cd4","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"69df3991-1f78-5988-a277-eba775516ffc","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"83991d80-1c24-5213-80d8-d98f94f7165f","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"9e55dced-d32c-53b0-9767-ec433fb86549","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"6a290b31-ff8d-56f2-aa28-4f7fc47c5ff6","slug":"ibuprofen","fullItemName":"Ibuprofen"}]},{"id":"0cb3e998-9c97-56e6-86e8-373f09a16cee","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"06233f93-f6af-5a86-a0d3-f66b18e22f6f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"933608bb-6634-5ada-9704-c47966180200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b65931da-6bf7-5353-a3e6-b7b3f0da241d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9e63923e-f250-5bb8-b436-8c4426b094d4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8a644bf0-15a8-56ea-a310-b3625c09b8ce","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4da49df8-81c2-588b-aaf2-014b7ddf9181","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"20d6c374-e4e4-55e9-8247-f63253537476","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"41fa1350-a42e-56da-b04d-aba216545b35","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"9ddbc2b4-b825-5eec-b14f-e39a0efa25ba","slug":"basis-for-recommendation-ccc","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 3fb3daea-01cf-48d9-8489-0e3344225de4 --><h3>Basis for recommendation</h3><!-- end field 3fb3daea-01cf-48d9-8489-0e3344225de4 -->","summary":null,"htmlStringContent":"<!-- begin item ccc555e0-255e-47a1-9144-831d52aca6ac --><!-- begin field d4780082-4a42-4666-8773-5b7869118498 --><p>These recommendations are based on expert opinion in the Public Health England (PHE) <em>Guidelines for the public health management of pertussis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>], and the PHE <em>Pertussis factsheet for healthcare professionals</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016d</a>].</p><ul><li>However, CKS is aware that successful culture may not be possible in primary care because [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Crowcroft and Pebody, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">Harnden, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whooping-cough/references/\">PHE, 2016b</a>]:<ul><li><em>B. pertussis</em> is a delicate organism and processing delays may therefore affect the likelihood of a positive culture.</li><li>Sensitivity is also highly dependent on specimen quality and is affected by increasing patient age, vaccination status and length of illness.</li><li>The likelihood of a positive culture decreases with time after symptom onset, from approximately 60% within 1 week of symptom onset to culture to 10% or less after 4 weeks. Cultures are unlikely to be positive in adolescents and adults with more than 3 weeks of coughing.</li><li>Culture requires collection using a nasopharyngeal/pernasal swab or nasopharyngeal aspirate, which are unpleasant and difficult to collect in primary care. Incorrect sampling technique may further reduce the sensitivity of culture.</li></ul></li></ul><!-- end field d4780082-4a42-4666-8773-5b7869118498 --><!-- end item ccc555e0-255e-47a1-9144-831d52aca6ac -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}